Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
18.24
+0.83 (4.77%)
At close: May 12, 2025, 4:00 PM
18.45
+0.21 (1.15%)
After-hours: May 12, 2025, 7:45 PM EDT
Beam Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Beam Therapeutics stock have an average target of 48.9, with a low estimate of 25 and a high estimate of 80. The average target predicts an increase of 168.09% from the current stock price of 18.24.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Beam Therapeutics stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 5 | 5 | 5 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 4 | 4 | 4 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $78 → $55 | Strong Buy | Maintains | $78 → $55 | +201.54% | May 7, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $75 → $70 | Buy | Maintains | $75 → $70 | +283.77% | May 7, 2025 |
| Barclays | Barclays | Hold Maintains $31 → $25 | Hold | Maintains | $31 → $25 | +37.06% | May 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +338.60% | Apr 7, 2025 |
| B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $42 | Hold → Strong Buy | Upgrades | $42 | +130.26% | Mar 28, 2025 |
Financial Forecast
Revenue This Year
60.96M
from 63.52M
Decreased by -4.02%
Revenue Next Year
64.82M
from 60.96M
Increased by 6.32%
EPS This Year
-4.90
from -4.58
EPS Next Year
-4.93
from -4.90
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 115.5M | 168.0M | 126.0M | ||
| Avg | 61.0M | 64.8M | 75.7M | ||
| Low | n/a | n/a | 29.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 81.8% | 175.6% | 94.4% | ||
| Avg | -4.0% | 6.3% | 16.8% | ||
| Low | - | - | -54.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -3.43 | -2.87 | -3.16 | ||
| Avg | -4.90 | -4.93 | -4.94 | ||
| Low | -5.87 | -6.10 | -6.25 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.